TIG Advisors LLC’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$151M Sell
2022
Q2
$150M Buy
2019
Q4
Sell
2019
Q3
$19.2M Sell
2019
Q2
$33.2M Buy